1. 1) Ichinose A: Japanese criterion 2012 for the diagnosis and treatment of acquired hemorrhaphilia XIII/13. 58th Annual Meeting of the Scientific and Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis (ISTH), June 27–30, 2012, ACC Liverpool (Liverpool, England); Ichinose A: An update on Japanese criterion 2012 for the diagnosis and treatment of autoimmune/acquired hemorrhaphilia XIII/13; a proposal of algorithm of laboratory tests and differential diagnosis. XXIV Congress of the International Society on Thrombosis and Haemostasis, 59th SSC Program, Subcommittee session, June 29–July 4, 2013, Amsterdam RAI (Amsterdam, The Netherlands)
2. 2) Lorand L. Acquired Inhibitors of Fibrin Stabilization: A Class of Hemorrhagic Disorders of Diverse Origins. In: Green D ed. Anticoagulants Physiologic, Pathologic, and Pharmacologic. CRC Press, 1994: 169–191.
3. 3) Egbring R, Kröniger A, Seitz R: Erworbene inhibitoren gegen Faktor XIII. Hamostaseologie 16: 174–179, 1996.
4. 4) Ichinose A; Japanese Collaborative Research Group (JCRG) on AH13 Hemorrhagic Acquired Coagulopathies: Inhibitors of Factor XIII/13 in older patients. Semin Thromb Hemost 40: 704–711, 2014.
5. 6) Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, Neunert C, Lillicrap D; ISTH/SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group: ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 8: 2063–2065, 2010.